跳至主要内容
临床试验/EUCTR2010-022874-15-GB
EUCTR2010-022874-15-GB进行中(未招募)不适用

Comparison of 30% nitrous oxide with therapeutic dose nimodipine on cerebral and systemic vascular physiology - Nitrous Oxide compared with nimodipine

niversity of Nottingham0 个研究点目标入组 20 人开始时间: 2010年10月13日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Males and Females aged between 18 and 50
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • People with history or evidence of cardiac or vascular disease.
  • Systemic illness.
  • Known hypersensitivity to nimodipine
  • People with evidence of a neurological disorder
  • People with liver disease
  • Pregnant or lactating females
  • Pneumothorax or emphysema.
  • People having received recent intraocular injection of gas (such as SF6).
  • Middle ear conditions.
  • People on the following prescription medication: Antihypertensives, Antiepileptics, Rifampicin, Macrolide antibiotics, Anti-HIV medication, Azole antimycotics, Antidepressants, Cimetidine.
  • Volunteers who are found to have evidence of carotid artery disease by Duplex scan screening will not take part in the study.
  • In females pregnancy will be excluded by an hCG test within 24 hours preceding MRI scan.

研究者

发起方
niversity of Nottingham

相似试验